Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04143100 · ClinicalTrials.gov registry record
Anxiety and Symptom Burden in Hemodialysis Patients
A clinical trial, sponsored by The Rogosin Institute.
- Completed
- Registry status
- 100
- Enrollment target
NCT04143100: Completed study, sponsored by The Rogosin Institute.
NCT04143100 is a clinical trial that has completed, run by The Rogosin Institute. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04143100 has completed, sponsored by The Rogosin Institute.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Anxiety has been identified as a prevalent and significant co-morbid condition in patients with End Stage Renal Disease (ESRD) being treated with hemodialysis. In particular, anxious sensitivity to symptoms commonly experienced by dialysis patients may lead patients to prematurely terminate their dialysis sessions and may have consequences on their dialysis adequacy and overall quality of life. The proposed study will examine the relationships between anxiety, depression, quality of life, symptom burden and dialysis prescription adherence. The primary regression analyses will be used to predict the influence of anxiety and depression (independently and together) on measures of adherence behaviors.
Primary Outcome
Anxiety measure - higher scores indicate more anxiety
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-08-30 |
| Est. Completion | 2020-12-31 |
What the finished NCT04143100 record still lists
NCT04143100 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT04143100 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04143100 about?
NCT04143100 is a clinical study titled "Anxiety and Symptom Burden in Hemodialysis Patients". Anxiety has been identified as a prevalent and significant co-morbid condition in patients with End Stage Renal Disease (ESRD) being treated with hemodialysis. In particular, anxious sensitivity to symptoms commonly experienced by dialysis patients may lead patients to prematurely terminate their di...
What is the current status of trial NCT04143100?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2019-08-30. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT04143100?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT04143100?
This trial is sponsored by The Rogosin Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI